Adocia
About
History
Management
Board of directors
Advisory board
Products and platforms
Pipeline
Technology Platforms
Careers
The « Adocians »
HR policy
Work environment
Join us
Partnering
Investors
Media
Contact
Contact us
Map and accessibility
Investors
Regulated information
Stock information
Corporate governance
General meeting
Media
Press releases
Media
EN
FR
Adocia announces new BioChaperone program combining a basal insulin and GLP-1s
Previous article
Adocia announces topline results of Indian Phase 3 trial of BioChaperone PDGF for diabetic foot ulcer
Next article
Adocia to Present Clinical Data Validating BioChaperone® Technology at the 2016 EASD Annual Meeting
